Vivo Capital, LLC - GRACELL BIOTECHNOLOGIES INC ownership

GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 33 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of GRACELL BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$31,337,695
+107.2%
10,881,144
+174.1%
3.43%
+228.8%
Q2 2023$15,123,517
+455.4%
3,969,427
+171.1%
1.04%
+452.4%
Q1 2023$2,723,008
+123057.3%
1,463,983
+52.3%
0.19%
-25.9%
Q4 2022$2,211
-99.9%
961,358
-0.0%
0.26%
-25.4%
Q3 2022$3,096,000
-41.4%
961,3590.0%0.34%
-35.6%
Q2 2022$5,287,000
+136.0%
961,3590.0%0.53%
+244.8%
Q1 2022$2,240,000
-61.4%
961,3590.0%0.15%
-56.0%
Q4 2021$5,807,000
-56.4%
961,3590.0%0.35%
-41.6%
Q3 2021$13,334,000
-22.8%
961,359
-27.6%
0.60%
-19.8%
Q2 2021$17,267,000
-26.4%
1,328,257
-12.8%
0.75%
-9.3%
Q1 2021$23,454,0001,522,9940.82%
Other shareholders
GRACELL BIOTECHNOLOGIES INC shareholders Q2 2021
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 3,445,973$8,029,0000.68%
Paradigm Biocapital Advisors LP 783,445$1,825,0000.48%
Orbimed Advisors 7,884,870$18,372,0000.30%
Vivo Capital, LLC 961,359$2,240,0000.15%
EcoR1 Capital, LLC 1,559,710$3,634,0000.11%
Temasek Holdings (Private) Ltd 9,901,940$23,071,5200.10%
Capital International, Inc./CA/ 2,335,476$5,442,0000.06%
Virtus ETF Advisers LLC 24,728$58,0000.03%
Capital International Sarl 228,149$532,0000.03%
FEDERATED HERMES, INC. 1,298,578$3,026,0000.01%
View complete list of GRACELL BIOTECHNOLOGIES INC shareholders